Bone tissue engineering in a critical size defect compared to ectopic implantations in the goat

被引:102
作者
Kruyt, MC
Dhert, WJA
Yuan, HP
Wilson, CE
van Blitterswijk, CA
Verbout, AJ
de Bruijn, JD
机构
[1] Univ Utrecht, Med Ctr, Dept Orthopaed, NL-3508 GA Utrecht, Netherlands
[2] IsoTis SA, NL-3723 MB Bilthoven, Netherlands
[3] Univ Twente, NL-7500 AE Enschede, Netherlands
关键词
bone; tissue engineering; cells; goat; ectopic; orthotopic;
D O I
10.1016/j.orthres.2003.10.010
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
Since the application of the autologous bone graft, the need for an alternative has been recognized. Tissue engineering (TE) of bone by combining bone marrow stromal cells (BMSCs) with a porous scaffold, is considered a promising technique. In this study we investigated the potential of tissue engineered bone to heal a critical sized defect in the goat. Orthotopic bone formation was compared to ectopic bone formation in comparable constructs. TE constructs were prepared from goat BMSCs and porous biphasic calcium phosphate ceramic scaffolds. These constructs and scaffolds without cells were implanted paired in critical sized iliac wing defects. Comparable samples were implanted intramuscularly. After 9 (n = 7) and 12 (n = 8) weeks implantation, the samples were analyzed histomorphometrically. After 9-weeks implantation in the iliac wing defect, significantly more bone apposition was found in the TE condition. After 12 weeks, the defects were almost completely filled with bone, but no significant advantage of TE was determined anymore. This contrasted with the intramuscular samples where TE implants showed significantly more bone at both time points. In conclusion, bone TE is feasible in critical sized defects. However, when appropriate osteoconductive/inductive materials are applied the effect of cell seeding may be temporary. (C) 2003 Orthopaedic Research Society. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:544 / 551
页数:8
相关论文
共 31 条
  • [1] LacZ and interleukin-3 expression in vivo after retroviral transduction of marrow-derived human osteogenic mesenchymal progenitors
    Allay, JA
    Dennis, JE
    Haynesworth, SE
    Majumdar, MK
    Clapp, DW
    Shultz, LD
    Caplan, AI
    Gerson, SL
    [J]. HUMAN GENE THERAPY, 1997, 8 (12) : 1417 - 1427
  • [2] Anderson MLC, 1999, CLIN ORTHOP RELAT R, P231
  • [3] Association of porous hydroxyapatite and bone marrow cells for bone regeneration
    Anselme, K
    Noël, B
    Flautre, B
    Blary, MC
    Delecourt, C
    Descamps, M
    Hardouin, P
    [J]. BONE, 1999, 25 (02) : 51S - 54S
  • [4] ILIAC CREST BONE-GRAFT HARVEST DONOR SITE MORBIDITY - A STATISTICAL EVALUATION
    BANWART, JC
    ASHER, MA
    HASSANEIN, RS
    [J]. SPINE, 1995, 20 (09) : 1055 - 1060
  • [5] BOLANDER ME, 1992, P SOC EXP BIOL MED, V200, P165
  • [6] Bone regeneration by implantation of purified, culture-expanded human mesenchymal stem cells
    Bruder, SP
    Kurth, AA
    Shea, M
    Hayes, WC
    Jaiswal, N
    Kadiyala, S
    [J]. JOURNAL OF ORTHOPAEDIC RESEARCH, 1998, 16 (02) : 155 - 162
  • [7] The effect of implants loaded with autologous mesenchymal stem cells on the healing of canine segmental bone defects
    Bruder, SP
    Kraus, KH
    Goldberg, VM
    Kadiyala, S
    [J]. JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 1998, 80A (07) : 985 - 996
  • [8] BURCHARDT H, 1983, CLIN ORTHOP RELAT R, P28
  • [9] BURWELL RG, 1985, CLIN ORTHOP RELAT R, P125
  • [10] Comparison of lumbar spine fusion using mixed and cloned marrow cells
    Cui, QJ
    Xiao, ZM
    Balian, G
    Wang, GJ
    [J]. SPINE, 2001, 26 (21) : 2305 - 2310